|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/574 | |
| A61K 31/553 | |||
| C12Q 1/68 |
| (11) | Patento numeris | 3314265 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16733928.2 |
| Europos patento paraiškos padavimo data | 2016-06-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-05-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-07-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2016/064920 |
| Data | 2016-06-28 |
| (87) | Numeris | WO 2017/001362 |
| Data | 2017-01-05 |
| (30) | Numeris | Data | Šalis |
| 201562186236 P | 2015-06-29 | US |
| (72) |
EDGAR, Kyle, US
FRIEDMAN, Lori, US
SAMPATH, Deepak, US
SONG, Kyung, US
WERTZ, Ingrid, US
WILSON, Timothy, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | METHODS OF TREATMENT WITH TASELISIB |
| METHODS OF TREATMENT WITH TASELISIB |